Publish monthly list of spurious drugs, DCGI tells state bodies
In a bid to protect consumers from the risks due to poor quality of medicines, cosmetics and medical devices, the Drug Controller General of India (DCGI) has asked the state drug inspectors to maintain a spurious drug list and publish it on monthly basis to avoid its further use.
The DCGI has come out with a guidance document for sampling of drugs, cosmetics and medical devices to ensure their better quality.
The document states the draft regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of central and state drug authorities. This guideline will be useful for effective surveillance for quality and efficacy of drugs and cosmetics by adopting uniform drug sampling methodology for drug inspectors under drug regulatory authorities of state and central.